Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

This study has been terminated.
Information provided by:
LEO Pharma Identifier:
First received: July 23, 2007
Last updated: August 23, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Estimated Primary Completion Date: No date given